Runs a network of clinics that treats workplace injuries and delivers employer-required health screening and exams, earning a fee each time a patient is seen or a service is performed.
- Returns appear driven by leverage
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $4.46B, above the global median of $1.2B
- FinancialsAltman Z-Score 2.33: grey zone
- Interpretations6 currently firing — 6
What this company is and how it runs — written from structure, not news.
The system sits between injured or newly hired workers, the employers who send them, and the insurers and third-party administrators who pay for their care. It takes a workplace injury or a compliance requirement, such as a drug screen or a fitness-for-duty exam, and turns it into a documented clinical outcome, a diagnosis, a clearance to return to work, or a test result, that the employer and payor can act on. Some of what it produces functions less like a routine medical visit and more like a compliance record that the employer or a regulator relies on. Money also moves through the system with a lag behind the care itself: the balance sheet shows a growing pool of amounts owed to it by the payors it bills, consistent with delivering treatment first and collecting afterward.
It charges in two different ways depending on how a location operates. At its own occupational-health centers and through its telemedicine service, it is paid a fee for each visit or service performed, in the manner of typical fee-for-service medical billing. At clinics it runs on an employer's own worksite, the employer instead reimburses the staffing and operating costs of that clinic plus a profit margin, so payment there works more like a service contract than a per-visit charge. Under this structure, the company has recorded a profit in every year for which CompanyGraph has recomputed its financial statements.
CompanyGraph reads this type of business as one where a single clinic's daily patient volume is capped, so growth tends to come from opening additional clinics and acquiring existing operations rather than from expanding volume at one location. The balance sheet is capital-heavy, and operating income has been rising while depreciation charges stay small relative to it, a combination consistent with a business still adding new capacity faster than its older assets are being written down. CompanyGraph also reads its returns as leaning on financial leverage: the return generated for equity holders looks high next to the underlying operating margin, a gap that borrowed capital, rather than the operating business alone, appears to explain. Its own disclosures describe ongoing new construction, and note that both new development and acquisitions require regulatory approval in the states where it operates.
CompanyGraph's mapping of this industry positions the company downstream of a wide range of upstream industries that feed into it. In its own filings, the company points to more specific dependencies: it relies on outside physician practices that operate some of its centers under management arrangements rather than direct ownership, on outside technology vendors such as Perry Johnson & Associates for medical transcription, and on transition services still supplied by Select Medical, its former parent, following the separation between the two companies.
Patients reach it through employers spanning many different industries, and revenue flows through the workers' compensation insurers and third-party administrators that manage claims on those employers' behalf, including named national carriers and administrators such as Sedgwick, Gallagher Bassett, Travelers, Liberty Mutual and Chubb, alongside separate administrators for services such as drug and alcohol screening. The company states that no single employer represents a large share of its revenue, and that its largest group of employer relationships together still makes up only a moderate share of the total, describing a customer base that is broad rather than concentrated. CompanyGraph's mapping of the industry also places it upstream of a smaller number of industries that rely on what it produces.
The company states that it is the largest occupational-health-services provider in the country by number of locations, by a wide margin over the next largest competitor focused solely on occupational health, and that most of its largest customers and longest-standing partners have stayed with it for a very long time. It also describes its data and communication connections with employers and partners as a source of stickiness. CompanyGraph treats these as the company's own claims about its position rather than an independent measure of how hard they would be for a competitor to replicate.
For employers that host an onsite clinic, the arrangement is built into their own worksite and staffed under a cost-plus contract, which is a deeper operational commitment than a simple purchase and would take real effort to unwind. The company also describes its data and communication connections with employers and referral partners as creating integration that makes switching away from it harder, and its own figures show that most of its largest customers and longest-standing partners have stayed with it for a very long time. These are the company's own descriptions of what keeps customers with it, not an independent measurement of switching cost.
In its own filings, the company points to labor, not physical plant, as the limit it names most: a shortage of qualified clinicians constrains how many of its facilities it can adequately staff. It also names regulatory friction, since opening new locations requires state facility licensing that can be slow and costly, and since new development and acquisitions can both be delayed by state review requirements. On pricing, it says state fee schedules and market pressure limit how much it can raise prices regardless of its own cost inflation. CompanyGraph's general view of this type of business is that the number of patients a single facility can see in a day is usually the binding limit on growth, a view this company's own account does not directly confirm or deny, since it does not disclose how close to capacity its facilities run.
The company's own filings name a specific set of risks first, ahead of others: workplace injuries and illnesses becoming less frequent, its relationships with major employers, payors and referral networks deteriorating, regulatory or state fee-schedule changes working against it, reimbursement rates rising more slowly than its costs, and difficulty finding and keeping enough clinical staff. It also flags continued reliance on transition services still supplied by Select Medical, its former parent, following their separation, as a dependency outside its direct control.
The company operates under oversight from multiple federal and state bodies: its clinicians are enrolled as Medicare suppliers, its dispensing locations require federal drug-enforcement registration, and its facilities are subject to state licensing, accreditation and workers' compensation regulation, any of which can change the terms under which it is paid or allowed to operate. It also names broader geopolitical and trade pressures, including tariff-related cost increases and possible disruption from international conflicts and tensions, as risks to its operations. Among the pressures it lists first are the possibility that workplace injuries become less frequent, changes in its relationships with the employers and payors it depends on, and reimbursement rates that move more slowly than its own costs.
Read from the company's own filings and public materials (gathered August 2026) together with figures CompanyGraph recomputed from its statements. Written September 2026. A question with no evidence behind it is left out rather than answered.
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
- Returns appear driven by leverage
6 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
High ROE Relative To Gross Margin
Its return on equity is high for the gross margin it earns, with revenue up three years and profit in all five.
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.